Table 5

Routine laboratory parameters: mean difference and standard deviation (SD) between treatment group (aVQ) and control group by independent t-test and result of the repeated measured analysis of variance (ANOVA, influence of treatment)
Values at baseline (SD) Difference between aVQ and control
aVQ Control t t t t F
at baseline at week 8 at week 16 at week 24 ANOVA
WBCx1000/μl 6.21 (2.13) 5.24 (1.17) −1.595 −2.1951* −2.0243 −2.1076* 7.614*
Platelets x1000/μl 61.38 (77.07) 72.19 (83.77) 0.38 −0.5491 0.2193 0.3207 0.0442
Neutrophils % 64.65 (8) 63.66 (8.29) −0.345 −0.7475 1.6094 −0.291 0.0055
Lymphocytes % 21.83 (6.37) 22.94 (7.51) 0.4493 2.1109* −0.068 1.0294 1.5019
Monocytes % 7.07 (2.91) 7.74 (3.69) 0.5746 0.5052 0.2823 0.8871 0.776
Eosinophils % 6.08 (3.89) 4.91 (2.39) −1.028 −3.677** −3.2466** −2.3029* 10.1286**
Basophiles % 0.37 (0.21) 0.76 (0.63) 2.3308* 0.4129 0.0282 −0.081 2.0996
Protein g/dl 6.16 (0.44) 6.31 (0.37) 1.0894 0.1437 0.3964 1.0308 0.4806
AST U/l+ 19.62 (4.26) 21 (8.48) 0.5798 0.4339 1.0689 0.4566 0.6618
ALT U/l 19.44 (9.39) 20.31 (11.27) 0.2386 0.064 1.3147 −0.0086 0.2651
ALK U/l‡ 65.75 (16.43) 72.56 (48.02) 0.5369 −2.146* −3.0221** −2.8479** 2.6545
Bilirubin mg/dl 0.84 (0.24) 0.79 (0.28) −0.471 −0.1546 −0.4448 −0.6975 0.2735

+AST: aspartate aminotransferase; ALT: alanine aminotransferase; ‡ ALK: alkaline phosphatase; *p<0.05 **p<0.01.

Kim et al.

Kim et al. BMC Complementary and Alternative Medicine 2012 12:172   doi:10.1186/1472-6882-12-172

Open Data